Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies
about
Surgery in 2013 and beyondRadiotherapy and the tumor stroma: the importance of dose and fractionationStereotactic radiotherapy for early lung cancer: Evidence-based approach and future directionsTreatment Plan Technique and Quality for Single-Isocenter Stereotactic Ablative Radiotherapy of Multiple Lung Lesions with Volumetric-Modulated Arc Therapy or Intensity-Modulated RadiosurgeryAdditional data in the debate on stage I non-small cell lung cancer: surgery versus stereotactic ablative radiotherapy.Axitinib Improves Radiotherapy in Murine Xenograft Lung Tumors.Stereotactic ablative radiotherapy (SABR) for lung cancer: What does the future hold?Stereotactic ablative radiotherapy for stage I NSCLC: Successes and existing challenges.Stereotactic body radiotherapy for Stage I lung cancer with chronic obstructive pulmonary disease: special reference to survival and radiation-induced pneumonitis.Double CT imaging can measure the respiratory movement of small pulmonary tumors during stereotactic ablative radiotherapy.Stereotactic body radiation therapy for a new lung cancer arising after pneumonectomy: dosimetric evaluation and pulmonary toxicityNon-small cell lung cancer therapy: safety and efficacy in the elderlyDifferential effect of soy isoflavones in enhancing high intensity radiotherapy and protecting lung tissue in a pre-clinical model of lung carcinoma.New techniques for assessing response after hypofractionated radiotherapy for lung cancerScalpel or SABR for Treatment of Early-Stage Lung Cancer: Clinical Considerations for the Multidisciplinary Team.Pulmonary imaging after stereotactic radiotherapy-does RECIST still apply?What is the current status of Stereotactic body radiotherapy for stage I non-small cell lung cancer?Changes in the Secretory Profile of NSCLC-Associated Fibroblasts after Ablative Radiotherapy: Potential Impact on Angiogenesis and Tumor Growth.Frameless stereotactic body radiation therapy for multiple lung metastases.
P2860
Q26863046-58CC2FDA-7175-4977-9C0D-0098FCD8685AQ27022685-5CEA376F-356A-469D-BB83-19D69A2DED67Q28085744-D04833BC-FF08-49B5-8D41-B5C44601DC6BQ30666911-3082EAEE-09D7-4EBC-829B-A87CF1E04919Q30993385-1068E8A0-F03E-41AC-8897-0252232A4084Q34092023-4E155F65-8289-4DF1-930E-014647B197D1Q35667834-92B46DEB-A744-4B8D-A4AC-E6083E435529Q35667866-CD120777-7A9C-473A-855B-74C3E649E727Q35835121-7E5C0934-FC7A-4328-BDDD-B10C5D9ACEFCQ36042363-288D67C4-6664-4010-883C-C4B3FBA28659Q36550532-374D96B7-1FBD-4423-ABC0-DE6B22912EC4Q36803114-E60885D6-3111-45A0-B57A-D275F73BA9B3Q37341807-91E5BA2F-E690-4D98-B6B7-F95A965614E1Q37670432-8A5C3C69-01BF-431C-9148-B747B16AB146Q38161371-07B13887-8896-458F-94E2-71D73DB12475Q38849150-0153341F-A210-43AE-95CF-44AA8DCDB085Q40342856-942C5136-B4E2-4615-9DCA-152969968962Q41810070-9A04D8A8-16DD-4A5B-A8C1-777783A5A929Q53052133-79C3313C-F6C4-432D-9BEC-A898D8070AB4
P2860
Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies
@ast
Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies
@en
type
label
Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies
@ast
Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies
@en
prefLabel
Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies
@ast
Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies
@en
P2093
P2860
P1476
Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies
@en
P2093
David A Palma
Frank J Lagerwaard
Suresh Senan
P2860
P304
P356
10.3978/J.ISSN.2072-1439.2011.05.03
P577
2011-09-01T00:00:00Z